Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. Thromb Haemost. 2016 07 04; 116(1):155-61.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Anticoagulants
Anticoagulants
Double-Blind Method
Double-Blind Method
Factor Xa Inhibitors
Factor Xa Inhibitors
Hemorrhage
Hemorrhage
Humans
Humans
Pyridines
Pyridines
Risk Factors
Risk Factors
Thiazoles
Thiazoles
Venous Thromboembolism
Venous Thromboembolism
Vitamin K
Vitamin K
Warfarin
Warfarin
authors with profiles
Gary E Raskob